Drug Shortage Report for TEVA-IRBESARTAN
Report ID | 217234 |
Drug Identification Number | 02316390 |
Brand name | TEVA-IRBESARTAN |
Common or Proper name | IRBESARTAN 75MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-24 |
Estimated end date | Unknown |
Actual end date | 2024-03-28 |
Shortage status | Resolved |
Updated date | 2024-04-01 |
Company comments | Item (Pack size) is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-04-01 | French | Compare |
v7 | 2024-04-01 | English | Compare |
v6 | 2024-02-15 | French | Compare |
v5 | 2024-02-15 | English | Compare |
v4 | 2024-02-01 | French | Compare |
v3 | 2024-02-01 | English | Compare |
v2 | 2024-01-25 | French | Compare |
v1 | 2024-01-25 | English | Compare |
Showing 1 to 8 of 8